South & Central America Diabetic Foot Ulcer Market Forecast to 2030

South & Central America Diabetic Foot Ulcer Market Forecast to 2030

South & Central America Diabetic Foot Ulcer Market Forecast to 2030 – Regional Analysis – By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)

Send Enquiry
Item ID: BMIRE00029574 Category: Tag:

$2,485 – $3,885

Description

The South & Central America diabetic foot ulcer market was valued at US$ 356.91 million in 2022 and is expected to reach US$ 549.39 million by 2030; it is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the South & Central America Diabetic Foot Ulcer Market

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

South & Central America Diabetic Foot Ulcer Market Overview

The South & Central America diabetic foot ulcer market is estimated to grow at a CAGR of 5.5% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth.

According to IDF Diabetes Atlas, in 2021, diabetes accounted for US$ 65 billion in expenditure in South & Central America, which is estimated to reach US$ 80 billion by 2030. Thus, the increasing healthcare spending and the rising prevalence of diabetes in the region are factors expected to boost market growth, ultimately increasing wound care product use. Additionally, several market players are implementing awareness and training courses to empower clinicians to enhance clinical knowledge and understand treatment options for chronic wounds such as diabetic foot ulcers. In April 2021, Medline launched a new series of chronic wound care courses in Argentina to train clinicians with advanced treatment options for diabetic foot ulcers. Such initiatives will support the market growth in Argentina.

South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the South & Central America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the South & Central America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the South & Central America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the South & Central America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the South & Central America diabetic foot ulcer market is segmented into Brazil, Argentina, the Rest of South & Central America. Brazil dominated the South & Central America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the South & Central America diabetic foot ulcer market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 5.5% CAGR, the South & Central America Diabetic Foot Ulcer Market is speculated to be worth US$ 549.39 million by 2030, says The Research Team.

According to The Research Team’ research, the South & Central America diabetic foot ulcer market was valued at US$ 356.91 in 2022 and is expected to reach US$ 549.39 million by 2030, registering a CAGR of 5.5% from 2022 to 2030. Growing research activities to unveil novel wound treatment products is among the critical factors attributed to the South & Central America diabetic foot ulcer market expansion.

Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. With the significant growth in the patient pool suffering from chronic wounds, such as diabetic foot ulcers, the need for a systematic treatment approach has accelerated, encouraging the adoption of evidence-based treatment to make wound care effective. Several research and clinical trials related to chronic wound management have demonstrated that bioactive wound care products help heal moist wounds more effectively than traditional wound care products. The active participation of government bodies and research organizations is promoting advancements in wound care treatments. Thus, the growing research activities and initiative by players will provide lucrative opportunities for the market growth.

On the contrary, high cost of advanced wound care treatments hampers the growth South & Central America diabetic foot ulcer market.

Based on treatment type, the South & Central America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held 53.8% share of the South & Central America diabetic foot ulcer market in 2022, amassing US$ 192.15 million. It is projected to garner US$ 301.09 million by 2030 to expand at 5.8% CAGR during 2022-2030.

Based on ulcer type, the South & Central America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held 50.5% share of the South & Central America diabetic foot ulcer market in 2022, amassing US$ 180.11 million. It is projected to garner US$ 283.94 million by 2030 to expand at 5.9% CAGR during 2022–2030.

Based on infection severity, the South & Central America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held 46.4% share of South & Central America diabetic foot ulcer market in 2022, amassing US$ 165.72 million. It is projected to garner US$ 263.32 million by 2030 to expand at 6.0% CAGR during 2022–2030.

Based on end user, the South & Central America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held 58.8% share of South & Central America diabetic foot ulcer market in 2022, amassing US$ 209.83 million. It is projected to garner US$ 334.18 million by 2030 to expand at 6.0% CAGR during 2022–2030.

Based on country, the South & Central America diabetic foot ulcer market is segmented into Brazil, Argentina, the Rest of South & Central America. Brazil held 69.9% share of South & Central America diabetic foot ulcer market in 2022, amassing US$ 249.44 million. It is projected to garner US$ 392.49 million by 2030 to expand at 5.8% CAGR during 2022–2030.

Key players operating in the South & Central America diabetic foot ulcer market are Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Mölnlycke Health Care AB, and MiMedx Group Inc, among others.

In Jul 2022, Smith+Nephew announced the launch of the WOUND COMPASS Clinical Support App. It is a comprehensive digital support tool for healthcare professionals that aids wound assessment and decision-making to help reduce practice variation. The App helps improve nurse confidence when assessing and treating wounds and reassuring specialist nurses that their formulary is followed.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America diabetic foot ulcer treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America diabetic foot ulcer treatment market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America diabetic foot ulcer treatment market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS


1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Diabetic Foot Ulcer Market Landscape
4.1 Overview
5. South & Central America Diabetic Foot Ulcer Market – Key Industry Dynamics
5.1 Market Drivers:
5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
5.1.2 Surge in Geriatric Population
5.2 Market Restraints
5.2.1 High Cost of Advanced Wound Care Treatments
5.3 Market Opportunities
5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.4 Future Trends
5.4.1 Use of 3D Printing in Wound Care Management
5.5 Impact Analysis:
6. Diabetic Foot Ulcer Market – South & Central America Market Analysis
6.1 South & Central America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – by Treatment Type
7.1 Overview
7.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
7.3.1 Overview
7.3.2 Advanced Wound Care Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Alginate Dressings
7.3.3.1 Overview
7.3.3.2 Alginate Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Hydrofiber Dressings
7.3.4.1 Overview
7.3.4.2 Hydrofiber Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Foam Dressings
7.3.5.1 Overview
7.3.5.2 Foam Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Collagen Dressing
7.3.6.1 Overview
7.3.6.2 Collagen Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.7 Film Dressing
7.3.7.1 Overview
7.3.7.2 Film Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.3.8 Other Dressings
7.3.8.1 Overview
7.3.8.2 Other Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
7.4.1 Overview
7.4.2 Biologics: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 Growth Factors
7.4.3.1 Overview
7.4.3.2 Growth Factors: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Skin Graft
7.4.4.1 Overview
7.4.4.2 Skin Graft: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
7.5.1 Overview
7.5.2 Therapy Device: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.3 Negative Pressure Wound Therapy
7.5.3.1 Overview
7.5.3.2 Negative Pressure Wound Therapy: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
7.5.4 Ultrasound Therapy
7.5.4.1 Overview
7.5.4.2 Ultrasound Therapy: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Ulcer Type
8.1 Overview
8.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
8.3.1 Overview
8.3.2 Neuropathic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
8.4.1 Overview
8.4.2 Ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
8.5.1 Overview
8.5.2 Neuro-ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By Infection Severity
9.1 Overview
9.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
9.3.1 Overview
9.3.2 Mild: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Moderate: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
9.3.4 Severe: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 – By End User
10.1 Overview
10.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
10.5.1 Overview
10.5.2 Home Care: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
11. Diabetic Foot Ulcer Market – South & Central America Market Analysis
11.1 South & Central America Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
11.1.1 Overview
11.1.1.1 South & Central America Diabetic Foot Ulcer Market by Country
11.1.1.2 Brazil
11.1.1.2.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.2.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.2.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.2.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.2.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.2.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.2.5 Brazil Diabetic Foot Ulcer Market, by End User
11.1.1.3 Argentina
11.1.1.3.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.3.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.3.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.3.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.3.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.3.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.3.5 Argentina Diabetic Foot Ulcer Market, by End User
11.1.1.4 Rest of South & Central America
11.1.1.4.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
11.1.1.4.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
11.1.1.4.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
11.1.1.4.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
11.1.1.4.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
11.1.1.4.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
11.1.1.4.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User
12. Diabetic Foot Ulcer Market Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Diabetic Foot Ulcer Market – Key Company Profiles
13.1 Convatec Group Plc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 3M Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Coloplast AS
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 B. Braun SE
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Molnlycke Health Care AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MiMedx Group Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Medline Industries LP
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Organogenesis Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Diabetic Foot Ulcer Market Segmentation
Table 2. South & Central America Diabetic Foot Ulcer Market, by Country – Revenue and Forecast to 2030 (USD Million)
Table 3. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 4. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 5. Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 6. Brazil: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 7. Brazil: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 8. Brazil Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 9. Brazil Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 10. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 11. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 12. Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 13. Argentina: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 14. Argentina: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 15. Argentina Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 16. Argentina Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 17. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Ulcer Type
Table 18. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) – Treatment Type
Table 19. Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings – Revenue and Forecast to 2030 (USD Million)
Table 20. Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
Table 21. Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
Table 22. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – Infection Severity
Table 23. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) – End User
Table 24. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 25. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
Table 26. Glossary of Terms, Diabetic Foot Ulcer Market

LIST OF FIGURES

Figure 1. South & Central America Diabetic Foot Ulcer Market Segmentation, By Country
Figure 2. South & Central America Diabetic Foot Ulcer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. South & Central America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 6. Advanced Wound Care Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Alginate Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Hydrofiber Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Foam Dressings: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Collagen Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Film Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Other Dressing: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Biologics: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Growth Factors: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Skin Graft: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Therapy Device: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Negative Pressure Wound Therapy: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ultrasound Therapy: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
Figure 20. Neuropathic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Neuro-ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
Figure 24. Mild: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Moderate: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Severe: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. South & Central America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
Figure 28. Hospitals: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Ambulatory Surgical Centers: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Home Care: South & Central America Diabetic Foot Ulcer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Diabetic Foot Ulcer Market, By Geography, 2022 ($Mn)
Figure 32. South & Central America Diabetic Foot Ulcer Market, By Key Countries, 2022 and 2030 (%)
Figure 33. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Growth Strategies in the Global Diabetic Foot Ulcer Market

The List of Companies – South & Central America Diabetic Foot Ulcer Market

1. Convatec Group Plc
2. 3M Co
3. Coloplast AS
4. Smith & Nephew Plc
5. B. Braun SE
6. Medline Industries LP
7. Organogenesis Inc.
8. Mölnlycke Health Care
9. MiMedx Group Inc

Reviews

There are no reviews yet.

Be the first to review “South & Central America Diabetic Foot Ulcer Market Forecast to 2030”